Stock Events

Stock Events

Taysha Gene Therapies (TSHA) Q4 2024 Earnings

13NovConfirmed

Q4 2023

Q2 2024

Q3 2024

Q4 2024

-0.16

-0.02

0.12

0.26

Details

Expected EPS

-0.086725

Actual EPS

-0.1

Surprise EPS

-0.01

Surprise Percent

+15.31%

Description

Taysha Gene Therapies (TSHA) has reported earnings of -0.1 per share for Q4 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.